Cargando…
Prevalence and clinical significance of serum sodium variability in patients with acute-on-chronic liver diseases: a prospective multicenter study in China
BACKGROUND: No reports exist regarding the prevalence of different Na levels and their relationship with 90-day prognosis in hospitalized patients with acute-on-chronic liver disease (AoCLD) in China. Therefore, the benefit of hyponatremia correction in AoCLD patients remains unclear. METHODS: We pr...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer India
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761510/ https://www.ncbi.nlm.nih.gov/pubmed/35037228 http://dx.doi.org/10.1007/s12072-021-10282-8 |
_version_ | 1784633542828883968 |
---|---|
author | Mei, Xue Li, Hai Deng, Guohong Wang, Xianbo Zheng, Xin Huang, Yan Chen, Jinjun Meng, Zhongji Gao, Yanhang Liu, Feng Lu, Xiaobo Shi, Yu Zheng, Yubao Yan, Huadong Zhang, Weituo Qiao, Liang Gu, Wenyi Zhang, Yan Xiang, Xiaomei Zhou, Yi Sun, Shuning Hou, Yixin Zhang, Qun Xiong, Yan Zou, Congcong Chen, Jun Huang, Zebing Li, Beiling Jiang, Xiuhua Zhong, Guotao Wang, Haiyu Chen, Yuanyuan Luo, Sen Gao, Na Liu, Chunyan Li, Jing Li, Tao Zheng, Rongjiong Zhou, Xinyi Ren, Haotang Yuan, Wei Qian, Zhiping |
author_facet | Mei, Xue Li, Hai Deng, Guohong Wang, Xianbo Zheng, Xin Huang, Yan Chen, Jinjun Meng, Zhongji Gao, Yanhang Liu, Feng Lu, Xiaobo Shi, Yu Zheng, Yubao Yan, Huadong Zhang, Weituo Qiao, Liang Gu, Wenyi Zhang, Yan Xiang, Xiaomei Zhou, Yi Sun, Shuning Hou, Yixin Zhang, Qun Xiong, Yan Zou, Congcong Chen, Jun Huang, Zebing Li, Beiling Jiang, Xiuhua Zhong, Guotao Wang, Haiyu Chen, Yuanyuan Luo, Sen Gao, Na Liu, Chunyan Li, Jing Li, Tao Zheng, Rongjiong Zhou, Xinyi Ren, Haotang Yuan, Wei Qian, Zhiping |
author_sort | Mei, Xue |
collection | PubMed |
description | BACKGROUND: No reports exist regarding the prevalence of different Na levels and their relationship with 90-day prognosis in hospitalized patients with acute-on-chronic liver disease (AoCLD) in China. Therefore, the benefit of hyponatremia correction in AoCLD patients remains unclear. METHODS: We prospectively collected the data of 3970 patients with AoCLD from the CATCH-LIFE cohort in China. The prevalence of different Na levels (≤ 120; 120–135; 135–145; > 145) and their relationship with 90-day prognosis were analyzed. For hyponatremic patients, we measured Na levels on days 4 and 7 and compared their characteristics, based on whether hyponatremia was corrected. RESULTS: A total of 3880 patients were involved; 712 of those developed adverse outcomes within 90 days. There were 80 (2.06%) hypernatremic, 28 (0.72%) severe hyponatremic, and 813 (20.95%) mild hyponatremic patients at admission. After adjusting for all confounding factors, the risk of 90-day adverse outcomes decreased by 5% (odds ratio [OR] 0.95; 95% confidence interval [CI] 0.93–0.97; p < 0.001), 24% (OR 0.76; 95% CI 0.70–0.84; p < 0.001), and 42% (OR 0.58; 95% CI 0.49–0.70; p < 0.001) as Na level increased by 1, 5, and 10 mmol/L, respectively. Noncorrection of hyponatremia on days 4 and 7 was associated with 2.05-fold (hazard ratio [HR], 2.05; 95% CI, 1.50–2.79; p < 0.001) and 1.46-fold (HR 1.46; 95% CI 1.05–2.02; p = 0.028) higher risk of adverse outcomes. CONCLUSIONS: Hyponatremia was an independent risk factor for a poor 90-day prognosis in patients with AoCLD. Failure to correct hyponatremia in a week after admission was often associated with increased mortality. (ClinicalTrials.gov number: NCT02457637, NCT03641872). CLINICAL TRIAL NUMBERS: This study is registered at Shanghai www.clinicaltrials.org (NCT02457637 and NCT03641872). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12072-021-10282-8. |
format | Online Article Text |
id | pubmed-8761510 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer India |
record_format | MEDLINE/PubMed |
spelling | pubmed-87615102022-01-18 Prevalence and clinical significance of serum sodium variability in patients with acute-on-chronic liver diseases: a prospective multicenter study in China Mei, Xue Li, Hai Deng, Guohong Wang, Xianbo Zheng, Xin Huang, Yan Chen, Jinjun Meng, Zhongji Gao, Yanhang Liu, Feng Lu, Xiaobo Shi, Yu Zheng, Yubao Yan, Huadong Zhang, Weituo Qiao, Liang Gu, Wenyi Zhang, Yan Xiang, Xiaomei Zhou, Yi Sun, Shuning Hou, Yixin Zhang, Qun Xiong, Yan Zou, Congcong Chen, Jun Huang, Zebing Li, Beiling Jiang, Xiuhua Zhong, Guotao Wang, Haiyu Chen, Yuanyuan Luo, Sen Gao, Na Liu, Chunyan Li, Jing Li, Tao Zheng, Rongjiong Zhou, Xinyi Ren, Haotang Yuan, Wei Qian, Zhiping Hepatol Int Original Article BACKGROUND: No reports exist regarding the prevalence of different Na levels and their relationship with 90-day prognosis in hospitalized patients with acute-on-chronic liver disease (AoCLD) in China. Therefore, the benefit of hyponatremia correction in AoCLD patients remains unclear. METHODS: We prospectively collected the data of 3970 patients with AoCLD from the CATCH-LIFE cohort in China. The prevalence of different Na levels (≤ 120; 120–135; 135–145; > 145) and their relationship with 90-day prognosis were analyzed. For hyponatremic patients, we measured Na levels on days 4 and 7 and compared their characteristics, based on whether hyponatremia was corrected. RESULTS: A total of 3880 patients were involved; 712 of those developed adverse outcomes within 90 days. There were 80 (2.06%) hypernatremic, 28 (0.72%) severe hyponatremic, and 813 (20.95%) mild hyponatremic patients at admission. After adjusting for all confounding factors, the risk of 90-day adverse outcomes decreased by 5% (odds ratio [OR] 0.95; 95% confidence interval [CI] 0.93–0.97; p < 0.001), 24% (OR 0.76; 95% CI 0.70–0.84; p < 0.001), and 42% (OR 0.58; 95% CI 0.49–0.70; p < 0.001) as Na level increased by 1, 5, and 10 mmol/L, respectively. Noncorrection of hyponatremia on days 4 and 7 was associated with 2.05-fold (hazard ratio [HR], 2.05; 95% CI, 1.50–2.79; p < 0.001) and 1.46-fold (HR 1.46; 95% CI 1.05–2.02; p = 0.028) higher risk of adverse outcomes. CONCLUSIONS: Hyponatremia was an independent risk factor for a poor 90-day prognosis in patients with AoCLD. Failure to correct hyponatremia in a week after admission was often associated with increased mortality. (ClinicalTrials.gov number: NCT02457637, NCT03641872). CLINICAL TRIAL NUMBERS: This study is registered at Shanghai www.clinicaltrials.org (NCT02457637 and NCT03641872). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12072-021-10282-8. Springer India 2022-01-17 /pmc/articles/PMC8761510/ /pubmed/35037228 http://dx.doi.org/10.1007/s12072-021-10282-8 Text en © Asian Pacific Association for the Study of the Liver 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Original Article Mei, Xue Li, Hai Deng, Guohong Wang, Xianbo Zheng, Xin Huang, Yan Chen, Jinjun Meng, Zhongji Gao, Yanhang Liu, Feng Lu, Xiaobo Shi, Yu Zheng, Yubao Yan, Huadong Zhang, Weituo Qiao, Liang Gu, Wenyi Zhang, Yan Xiang, Xiaomei Zhou, Yi Sun, Shuning Hou, Yixin Zhang, Qun Xiong, Yan Zou, Congcong Chen, Jun Huang, Zebing Li, Beiling Jiang, Xiuhua Zhong, Guotao Wang, Haiyu Chen, Yuanyuan Luo, Sen Gao, Na Liu, Chunyan Li, Jing Li, Tao Zheng, Rongjiong Zhou, Xinyi Ren, Haotang Yuan, Wei Qian, Zhiping Prevalence and clinical significance of serum sodium variability in patients with acute-on-chronic liver diseases: a prospective multicenter study in China |
title | Prevalence and clinical significance of serum sodium variability in patients with acute-on-chronic liver diseases: a prospective multicenter study in China |
title_full | Prevalence and clinical significance of serum sodium variability in patients with acute-on-chronic liver diseases: a prospective multicenter study in China |
title_fullStr | Prevalence and clinical significance of serum sodium variability in patients with acute-on-chronic liver diseases: a prospective multicenter study in China |
title_full_unstemmed | Prevalence and clinical significance of serum sodium variability in patients with acute-on-chronic liver diseases: a prospective multicenter study in China |
title_short | Prevalence and clinical significance of serum sodium variability in patients with acute-on-chronic liver diseases: a prospective multicenter study in China |
title_sort | prevalence and clinical significance of serum sodium variability in patients with acute-on-chronic liver diseases: a prospective multicenter study in china |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761510/ https://www.ncbi.nlm.nih.gov/pubmed/35037228 http://dx.doi.org/10.1007/s12072-021-10282-8 |
work_keys_str_mv | AT meixue prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina AT lihai prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina AT dengguohong prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina AT wangxianbo prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina AT zhengxin prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina AT huangyan prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina AT chenjinjun prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina AT mengzhongji prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina AT gaoyanhang prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina AT liufeng prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina AT luxiaobo prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina AT shiyu prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina AT zhengyubao prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina AT yanhuadong prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina AT zhangweituo prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina AT qiaoliang prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina AT guwenyi prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina AT zhangyan prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina AT xiangxiaomei prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina AT zhouyi prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina AT sunshuning prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina AT houyixin prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina AT zhangqun prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina AT xiongyan prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina AT zoucongcong prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina AT chenjun prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina AT huangzebing prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina AT libeiling prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina AT jiangxiuhua prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina AT zhongguotao prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina AT wanghaiyu prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina AT chenyuanyuan prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina AT luosen prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina AT gaona prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina AT liuchunyan prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina AT lijing prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina AT litao prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina AT zhengrongjiong prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina AT zhouxinyi prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina AT renhaotang prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina AT yuanwei prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina AT qianzhiping prevalenceandclinicalsignificanceofserumsodiumvariabilityinpatientswithacuteonchronicliverdiseasesaprospectivemulticenterstudyinchina |